Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
PROMAZINE
(1956)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
PROMAZINE
×
Maximum Phase:
4
First Approval:
1956
UNII:
O9M39HTM5W
Molecule Type:
Small molecule
Molecular Formula:
C17H20N2S
Molecular Weight:
284.43
AlogP:
4.24
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MECAMYLAMINE HYDROCHLORIDE
(1956)
Small molecule
Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator
ORAL
Approved
Unknown
MECAMYLAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1956
UNII:
4956DJR58O
Molecule Type:
Small molecule
Molecular Formula:
C11H22ClN
Molecular Weight:
203.76
AlogP:
2.42
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
1.0
Source:
TETRACYCLINE PHOSPHATE COMPLEX
(1957)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Unknown
TETRACYCLINE PHOSPHATE COMPLEX
×
Maximum Phase:
4
First Approval:
1957
UNII:
6B7BK5H33B
Molecule Type:
Small molecule
Molecular Formula:
C22H27N2O12P
Molecular Weight:
542.43
AlogP:
-0.21
PSA:
181.62
HBD:
6.0
HBA:
#RotB:
2.0
Source:
ISOPROPAMIDE IODIDE
(1957)
Small molecule
Muscarinic acetylcholine receptor M1 antagonist
ORAL
Approved
Unknown
ISOPROPAMIDE IODIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
E0KNA372SZ
Molecule Type:
Small molecule
Molecular Formula:
C23H33IN2O
Molecular Weight:
480.43
AlogP:
4.11
PSA:
43.09
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PERPHENAZINE
(1957)
Small molecule
Dopamine D2 receptor antagonist
INJECTION; ORAL
Approved
Postoperative Nausea and Vomiting; Psychotic Disorders; Schizophrenia
PERPHENAZINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
FTA7XXY4EZ
Molecule Type:
Small molecule
Molecular Formula:
C21H26ClN3OS
Molecular Weight:
403.98
AlogP:
3.94
PSA:
29.95
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CHLORAMBUCIL
(1957)
Small molecule
DNA inhibitor
ORAL
Approved
Hodgkin Disease; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
CHLORAMBUCIL
×
Maximum Phase:
4
First Approval:
1957
UNII:
18D0SL7309
Molecule Type:
Small molecule
Molecular Formula:
C14H19Cl2NO2
Molecular Weight:
304.22
AlogP:
3.38
PSA:
40.54
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ISOPROPAMIDE
(1957)
Small molecule
Unknown
Unknown
Approved
Digestive System Diseases
ISOPROPAMIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
8B9I31H724
Molecule Type:
Small molecule
Molecular Formula:
C23H33N2O+
Molecular Weight:
353.53
AlogP:
4.11
PSA:
43.09
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PROPOXYPHENE HYDROCHLORIDE
(1957)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Pain
PROPOXYPHENE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
CB2TL9PS0T
Molecule Type:
Small molecule
Molecular Formula:
C22H30ClNO2
Molecular Weight:
375.94
AlogP:
4.28
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
METHSUXIMIDE
(1957)
Small molecule
Voltage-gated T-type calcium channel blocker
ORAL
Approved
Epilepsy; Seizures
METHSUXIMIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
0G76K8X6C0
Molecule Type:
Small molecule
Molecular Formula:
C12H13NO2
Molecular Weight:
203.24
AlogP:
1.33
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
1.0
Source:
NEOMYCIN
(1957)
Small molecule
Bacterial 70S ribosome inhibitor
Unknown
Investigational
Unknown
NEOMYCIN
×
Maximum Phase:
4
First Approval:
1957
UNII:
I16QD7X297
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIFLUPROMAZINE
(1957)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Psychotic Disorders
TRIFLUPROMAZINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
RO16TQF95Y
Molecule Type:
Small molecule
Molecular Formula:
C18H19F3N2S
Molecular Weight:
352.43
AlogP:
5.26
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ANISINDIONE
(1957)
Small molecule
Vitamin K-dependent gamma-carboxylase inhibitor
ORAL
Approved
Unknown
ANISINDIONE
×
Maximum Phase:
4
First Approval:
1957
UNII:
S747T1ERAJ
Molecule Type:
Small molecule
Molecular Formula:
C16H12O3
Molecular Weight:
252.27
AlogP:
2.86
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
2.0
Source:
POLYESTRADIOL PHOSPHATE
(1957)
Small molecule
Estrogen receptor alpha agonist
INJECTION
Approved
Unknown
POLYESTRADIOL PHOSPHATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
P14877CDX2
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BROMPHENIRAMINE MALEATE
(1957)
Small molecule
Histamine H1 receptor antagonist
INJECTION; ORAL
Approved
Common Cold; Cough; Hypersensitivity
BROMPHENIRAMINE MALEATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
IXA7C9ZN03
Molecule Type:
Small molecule
Molecular Formula:
C20H23BrN2O4
Molecular Weight:
435.32
AlogP:
3.93
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
MECLIZINE
(1957)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
MECLIZINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
3L5TQ84570
Molecule Type:
Small molecule
Molecular Formula:
C25H27ClN2
Molecular Weight:
390.96
AlogP:
5.56
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PROCHLORPERAZINE EDISYLATE
(1957)
Small molecule
Dopamine D2 receptor antagonist
INJECTION; ORAL
Approved
Unknown
PROCHLORPERAZINE EDISYLATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
PG20W5VQZS
Molecule Type:
Small molecule
Molecular Formula:
C22H30ClN3O6S3
Molecular Weight:
564.15
AlogP:
4.58
PSA:
9.72
HBD:
0.0
HBA:
#RotB:
4.0
Source:
SODIUM PHOSPHATE
(1957)
Small molecule
Saline laxative
Unknown
Approved
Constipation
SODIUM PHOSPHATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
SE337SVY37
Molecule Type:
Small molecule
Molecular Formula:
HNa2O4P
Molecular Weight:
141.96
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ORPHENADRINE HYDROCHLORIDE
(1957)
Small molecule
Glutamate [NMDA] receptor antagonist
ORAL
Approved
Parkinson Disease
ORPHENADRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
UBY910DUXH
Molecule Type:
Small molecule
Molecular Formula:
C18H24ClNO
Molecular Weight:
305.85
AlogP:
3.66
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
6.0
Source:
DESERPIDINE
(1957)
Small molecule
Synaptic vesicular amine transporter inhibitor
ORAL
Approved
Hypertension
DESERPIDINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
9016E3VB47
Molecule Type:
Small molecule
Molecular Formula:
C32H38N2O8
Molecular Weight:
578.66
AlogP:
4.16
PSA:
108.55
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CHLORPROMAZINE HYDROCHLORIDE
(1957)
Small molecule
D2-like dopamine receptor antagonist
INJECTION; ORAL
Approved
Unknown
CHLORPROMAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
9WP59609J6
Molecule Type:
Small molecule
Molecular Formula:
C17H20Cl2N2S
Molecular Weight:
355.33
AlogP:
4.89
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ORPHENADRINE
(1957)
Small molecule
Unknown
Unknown
Approved
Unknown
ORPHENADRINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
AL805O9OG9
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO
Molecular Weight:
269.39
AlogP:
3.66
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
6.0
Source:
MECLIZINE HYDROCHLORIDE
(1957)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Motion Sickness; Nausea; Postoperative Nausea and Vomiting; Vertigo; Vomiting
MECLIZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
HDP7W44CIO
Molecule Type:
Small molecule
Molecular Formula:
C25H31Cl3N2O
Molecular Weight:
481.9
AlogP:
5.56
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
5.0
Source:
SODIUM PHOSPHATE P 32
(1957)
Small molecule
Unknown
Unknown
Approved
Unknown
SODIUM PHOSPHATE P 32
×
Maximum Phase:
4
First Approval:
1957
UNII:
O181101B5G
Molecule Type:
Small molecule
Molecular Formula:
HNa2O4P
Molecular Weight:
142.96
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PHENPROCOUMON
(1957)
Small molecule
Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
ORAL
Approved
Thrombosis
PHENPROCOUMON
×
Maximum Phase:
4
First Approval:
1957
UNII:
Q08SIO485D
Molecule Type:
Small molecule
Molecular Formula:
C18H16O3
Molecular Weight:
280.32
AlogP:
4.04
PSA:
50.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
NEOMYCIN SULFATE
(1957)
Small molecule
Bacterial 70S ribosome inhibitor
FOR RX COMPOUNDING; ORAL
Approved
Unknown
NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
057Y626693
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPROMAZINE
(1957)
Small molecule
D2-like dopamine receptor antagonist
RECTAL
Approved
Conduct Disorder; Porphyrias; Postoperative Nausea and Vomiting; Psychotic Disorders; Schizophrenia
CHLORPROMAZINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
U42B7VYA4P
Molecule Type:
Small molecule
Molecular Formula:
C17H19ClN2S
Molecular Weight:
318.87
AlogP:
4.89
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
METHYLPREDNISOLONE
(1957)
Small molecule
Glucocorticoid receptor agonist
ORAL
Approved
Acne Vulgaris; Arthritis, Psoriatic; Arthritis, Rheumatoid; Asthma; Bursitis; Colitis, Ulcerative; Crohn Disease; Dermatitis, Atopic; Inflammation; Multiple Sclerosis; Osteoarthritis; Pneumonia; Tenosynovitis
METHYLPREDNISOLONE
×
Maximum Phase:
4
First Approval:
1957
UNII:
X4W7ZR7023
Molecule Type:
Small molecule
Molecular Formula:
C22H30O5
Molecular Weight:
374.48
AlogP:
1.8
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
2.0
Source:
TRIFLUPROMAZINE HYDROCHLORIDE
(1957)
Small molecule
Dopamine D2 receptor antagonist
INJECTION; ORAL
Approved
Unknown
TRIFLUPROMAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1957
UNII:
9E75N4A5HM
Molecule Type:
Small molecule
Molecular Formula:
C18H20ClF3N2S
Molecular Weight:
388.89
AlogP:
5.26
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
4.0
Source:
ISOFLUROPHATE
(1957)
Small molecule
Acetylcholinesterase inhibitor
OPHTHALMIC
Approved
Glaucoma
ISOFLUROPHATE
×
Maximum Phase:
4
First Approval:
1957
UNII:
12UHW9R67N
Molecule Type:
Small molecule
Molecular Formula:
C6H14FO3P
Molecular Weight:
184.15
AlogP:
2.91
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
4.0
Source:
PROPOXYPHENE
(1957)
Small molecule
Unknown
Unknown
Approved
Pain
PROPOXYPHENE
×
Maximum Phase:
4
First Approval:
1957
UNII:
S2F83W92TK
Molecule Type:
Small molecule
Molecular Formula:
C22H29NO2
Molecular Weight:
339.48
AlogP:
4.28
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
8.0
Source:
METHOCARBAMOL
(1957)
Small molecule
Carbonic anhydrase I inhibitor
IM-IV; INJECTION; ORAL
Approved
Unknown
METHOCARBAMOL
×
Maximum Phase:
4
First Approval:
1957
UNII:
125OD7737X
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO5
Molecular Weight:
241.24
AlogP:
0.53
PSA:
91.01
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TRIAMCINOLONE
(1957)
Small molecule
Glucocorticoid receptor agonist
ORAL
Approved
Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction; Skin Diseases
TRIAMCINOLONE
×
Maximum Phase:
4
First Approval:
1957
UNII:
1ZK20VI6TY
Molecule Type:
Small molecule
Molecular Formula:
C21H27FO6
Molecular Weight:
394.44
AlogP:
0.62
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
2.0
Source:
ETHOTOIN
(1957)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Epilepsy; Seizures
ETHOTOIN
×
Maximum Phase:
4
First Approval:
1957
UNII:
46QG38NC4U
Molecule Type:
Small molecule
Molecular Formula:
C11H12N2O2
Molecular Weight:
204.23
AlogP:
1.3
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BROMPHENIRAMINE
(1957)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
BROMPHENIRAMINE
×
Maximum Phase:
4
First Approval:
1957
UNII:
H57G17P2FN
Molecule Type:
Small molecule
Molecular Formula:
C16H19BrN2
Molecular Weight:
319.25
AlogP:
3.93
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
FURAZOLIDONE
(1958)
Small molecule
DNA inhibitor
ORAL
Approved
Unknown
FURAZOLIDONE
×
Maximum Phase:
4
First Approval:
1958
UNII:
5J9CPU3RE0
Molecule Type:
Small molecule
Molecular Formula:
C8H7N3O5
Molecular Weight:
225.16
AlogP:
0.97
PSA:
98.18
HBD:
0.0
HBA:
#RotB:
3.0
Source:
CHLORPROPAMIDE
(1958)
Small molecule
Sulfonylurea receptor 1, Kir6.2 blocker
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
CHLORPROPAMIDE
×
Maximum Phase:
4
First Approval:
1958
UNII:
WTM2C3IL2X
Molecule Type:
Small molecule
Molecular Formula:
C10H13ClN2O3S
Molecular Weight:
276.75
AlogP:
1.74
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
4.0
Source:
1
2
…
5
6
7
8
9
10
11
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA